Publications by authors named "Xuanling Shi"

Claim this Profile
E
Exploring distinct modes of inter-spike cross-linking for enhanced neutralization by SARS-CoV-2 antibodies.
Xuanyu Nan, Yujie Li, Rui Zhang, Ruoke Wang, Niannian Lv, Xuanling Shi

Nat Commun· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
DS2 designer pre-fusion F vaccine induces strong and protective antibody response against RSV infection.
Yiling Yang, Ruoke Wang, Fenglin Guo, Tian Zhao, Yuqing Lei, Xuanling Shi

NPJ Vaccines· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Super broad and protective nanobodies against Sarbecoviruses including SARS-CoV-1 and the divergent SARS-CoV-2 subvariant KP.3.1.1.
Haodi Dong, Runhong Zhou, Jing Chen, Jing Wei, Zimeng Wei, Xuanling Shi

PLoS Pathog· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dissecting the intricacies of human antibody responses to SARS-CoV-1 and SARS-CoV-2 infection.
Ruoke Wang, Yang Han, Rui Zhang, Jiayi Zhu, Xuanyu Nan, Xuanling Shi

Immunity· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Infection with wild-type SARS-CoV-2 elicits broadly neutralizing and protective antibodies against omicron subvariants.
Bin Ju, Qi Zhang, Ziyi Wang, Zhen Qin Aw, Peng Chen, Xuanling Shi

Nat Immunol· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Novel TLR7/8 agonists promote activation of HIV-1 latent reservoirs and human T and NK cells.
Yangyang Li, Zhisong Wang, Ying Hou, Xiaoyu Liu, Junxian Hong, Xuanling Shi

Front Microbiol· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Broadly neutralizing and protective nanobodies against SARS-CoV-2 Omicron subvariants BA.1, BA.2, and BA.4/5 and diverse sarbecoviruses.
Mingxi Li, Yifei Ren, Zhen Qin Aw, Bo Chen, Ziqing Yang, Xuanling Shi

Nat Commun· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Structural basis of a two-antibody cocktail exhibiting highly potent and broadly neutralizing activities against SARS-CoV-2 variants including diverse Omicron sublineages.
Xiaoman Li, Yongbing Pan, Qiangling Yin, Zejun Wang, Sisi Shan, Xuanling Shi, Shiwen Wang

Cell Discov· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
SARS-CoV-2 Omicron Variants Reduce Antibody Neutralization and Acquire Usage of Mouse ACE2.
Ruoke Wang, Qi Zhang, Rui Zhang, Zhen Qin Aw, Peng Chen, Xuanling Shi

Front Immunol· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
RBD trimer mRNA vaccine elicits broad and protective immune responses against SARS-CoV-2 variants.
Qingtai Liang, Yifeng Wang, Shuyuan Zhang, Jing Sun, Wenbo Sun, Xuanling Shi

iScience· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Deep learning guided optimization of human antibody against SARS-CoV-2 variants with broad neutralization.
Sisi Shan, Shitong Luo, Ziqing Yang, Junxian Hong, Yufeng Su, Xuanling Shi

Proc Natl Acad Sci U S A· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Potent and Protective Human Neutralizing Antibody Against SARS-CoV-2 Variants.
Sisi Shan, Chee Keng Mok, Shuyuan Zhang, Jun Lan, Jizhou Li, Xuanling Shi

Front Immunol· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A potent and protective human neutralizing antibody targeting a novel vulnerable site of Epstein-Barr virus.
Qian-Ying Zhu, Sisi Shan, Jinfang Yu, Si-Ying Peng, Cong Sun, Xuanling Shi

Nat Commun· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Analysis of SARS-CoV-2 variant mutations reveals neutralization escape mechanisms and the ability to use ACE2 receptors from additional species.
Ruoke Wang, Qi Zhang, Jiwan Ge, Wenlin Ren, Rui Zhang, Xuanling Shi

Immunity· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Role of efficient testing and contact tracing in mitigating the COVID-19 pandemic: a network modelling study.
Yiying Hu, Jianying Guo, Guanqiao Li, Xi Lu, Xiang Li, Xuanling Shi

BMJ Open· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Potent and protective IGHV3-53/3-66 public antibodies and their shared escape mutant on the spike of SARS-CoV-2.
Qi Zhang, Bin Ju, Jiwan Ge, Jasper Fuk-Woo Chan, Lin Cheng, Xuanling Shi

Nat Commun· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Single-Dose Immunization With a Chimpanzee Adenovirus-Based Vaccine Induces Sustained and Protective Immunity Against SARS-CoV-2 Infection.
Mingxi Li, Jingao Guo, Shuaiyao Lu, Runhong Zhou, Hongyang Shi, Xuanling Shi

Front Immunol· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An integrated framework for modelling quantitative effects of entry restrictions and travel quarantine on importation risk of COVID-19.
Tiange Chen, Siwan Huang, Guanqiao Li, Yuan Zhang, Ye Li, Xuanling Shi

J Biomed Inform· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Differential impact of non-pharmaceutical public health interventions on COVID-19 epidemics in the United States.
Xiaoshuang Liu, Xiao Xu, Guanqiao Li, Xian Xu, Yuyao Sun, Xuanling Shi

BMC Public Health· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antibody neutralization of SARS-CoV-2 through ACE2 receptor mimicry.
Jiwan Ge, Ruoke Wang, Bin Ju, Qi Zhang, Jing Sun, Xuanling Shi

Nat Commun· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Stabilized diverse HIV-1 envelope trimers for vaccine design.
Qian Wang, Bingting Ma, Qingtai Liang, Angqi Zhu, Hua Wang, Xuanling Shi

Emerg Microbes Infect· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Establishment of replication-competent vesicular stomatitis virus-based recombinant viruses suitable for SARS-CoV-2 entry and neutralization assays.
Hongyue Li, Chaoyue Zhao, Yuhang Zhang, Fei Yuan, Qi Zhang, Xuanling Shi

Emerg Microbes Infect· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development of a Potent and Protective Germline-Like Antibody Lineage Against Zika Virus in a Convalescent Human.
Fei Gao, Xiaohe Lin, Linling He, Ruoke Wang, Han Wang, Xuanling Shi

Front Immunol· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Human neutralizing antibodies elicited by SARS-CoV-2 infection.
Bin Ju, Qi Zhang, Jiwan Ge, Ruoke Wang, Jing Sun, Xuanling Shi

Nature· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Structure of the SARS-CoV-2 spike receptor-binding domain bound to the ACE2 receptor.
Jun Lan, Jiwan Ge, Jinfang Yu, Sisi Shan, Huan Zhou, Shilong Fan, Xuanling Shi

Nature· May 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis